Transcatheter device closure of patent ductus arteriosus without arterial access – Single institution experience

Abstract

Objective: Retrospective analysis of feasibility, safety and advantages of device closure of patent ductus arteriosus (PDA) using only venous access. Background: Arterial access for transcatheter device closure of PDA has been a standard practice, but has inherent complications, especially in infants. Method: Records of patients who underwent PDA device closure from 2004 to 2012 were reviewed. Echocardiography was used for patient selection and for assessment of procedural outcome. Result: 151 out of 179 patients underwent PDA device closure with venous access alone, weighing 2.2–58 kg with half <10 kg and follow up of 6 months–8 years. Fluoroscopic time ranged from 2.2 to 16 min. Immediate closure was achieved in 146 patients. Two patients had new-onset left pulmonary artery turbulence and one had residual flow. Conclusion: PDA device closure without arterial access can be accomplished safely and effectively in vast majority of patients including infants.

Keywords

• PDA device
• Arterial access
• Heparinization